Tolvaptan
Ended Awarded
- Contract number
- 36C25220F0386
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,102
Award facts
- Contract value 100% obligated
- $10,102.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
On August 3, 2020, the Department of Veterans Affairs, through Veterans Integrated Service Network 12, awarded a delivery order to Otsuka America Pharmaceutical Inc. for the supply of Tolvaptan with a ceiling value of $10,102.19. This firm-fixed price delivery order, with an ultimate completion date of August 10, 2020, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize a set-aside designation. The place of performance is Pittsburgh, Pennsylvania. Tolvaptan, marketed as Jynarque by Otsuka, is a specialized pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veterans.
This delivery order is issued against a larger Blanket Purchase Agreement valued at $83.3 million, which Otsuka America Pharmaceutical Inc. maintains with the VA's National Acquisition Center for the supply of Jynarque across multiple Veterans Integrated Service Networks. Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, is registered in the System for Award Management and has established itself as a primary supplier of specialty pharmaceuticals to the VA's Veterans Health Administration. The delivery order supports the agency's mission to provide advanced pharmaceutical treatments to veterans nationwide through streamlined federal procurement mechanisms.
Quick answers
Who was awarded contract 36C25220F0386?
36C25220F0386 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on August 3, 2020.
How much is contract 36C25220F0386 worth?
The government has obligated $10,102 on 36C25220F0386.
Is contract 36C25220F0386 an order under another contract?
Yes. 36C25220F0386 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25220F0386 competed?
The extent of competition for 36C25220F0386 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award